DelMar pharmaceuticals
  • About
  • Pipeline
  • Clinical Trial
  • Investors
  • News
  • Contact

Press Releases

  • Investor Relations
  • Press Releases
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Media Coverage
    • Email Alerts
  • Company Blog
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Quick Links
  • Email Alerts
  • Corporate Presentation
  • Contacts for Investors
  • RSS News Feed

Press Releases

  • All News
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016

July 21, 2016

DelMar Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell on July 14

July 13, 2016

DelMar Pharmaceuticals Announces Approval for Listing on NASDAQ

July 11, 2016

DelMar Pharmaceuticals Presents Phase I/II GBM Clinical Trial Data and Outlines Future Clinical Development Plans at ASCO 2016 Annual Meeting

June 6, 2016

DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 for the Treatment of Refractory Glioblastoma Multiforme

May 25, 2016

DelMar Pharmaceuticals Announces Reverse Stock Split in Preparation for Proposed Senior Exchange Uplisting

May 19, 2016

DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2016 Financial Results and Corporate Update

May 13, 2016

DelMar Pharmaceuticals, Inc. Announces $5.6 Million Private Placement Of Preferred Shares

May 5, 2016

FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer

April 21, 2016

DelMar Pharmaceuticals Updates Ongoing Phase I/II Refractory GBM Clinical Trial with VAL-083 at American Association Cancer Research (AACR) Annual Meeting

April 19, 2016

RSS
  • « Previous
  • 1
  • 2
  • 3
  • Next »
  • Connect with Us
Delmar Icon
  • About
  • Pipeline
  • Clinical trial
  • Investors
  • News
  • Contact
© Copyright 2018 Del Mar Pharmaceuticals, Inc. All Rights Reserved.